PERSPECTIVE THERAPEUTICS INC (CATX) — insider trading
Health Care · NYSE American
PERSPECTIVE THERAPEUTICS INC (CATX) has 18 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases and 7 open-market sales among the most recent 18 (latest 2026-09-04).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | Lantheus Alpha Therapy, LLC; Lantheus Holdings, Inc. | 10% owner | Open-market sale | 167,149 | $3.15 | $526.1K | Form 4 |
| 2026-09-03 | Lantheus Alpha Therapy, LLC; Lantheus Holdings, Inc. | 10% owner | Open-market sale | 80,783 | $3.11 | $250.9K | Form 4 |
| 2026-09-02 | Lantheus Alpha Therapy, LLC; Lantheus Holdings, Inc. | 10% owner | Open-market sale | 42,129 | $3.11 | $131.2K | Form 4 |
| 2026-09-01 | Lantheus Alpha Therapy, LLC | 10% owner | Open-market sale | 35,769 | $3.12 | $111.6K | Form 4 |
| 2026-09-01 | Lantheus Holdings, Inc. | 10% owner | Open-market sale | 35,769 | $3.12 | $111.6K | Form 4 |
| 2026-08-31 | Lantheus Alpha Therapy, LLC | 10% owner | Open-market sale | 78,145 | $3.14 | $245.6K | Form 4 |
| 2026-08-31 | Lantheus Holdings, Inc. | 10% owner | Open-market sale | 78,145 | $3.14 | $245.6K | Form 4 |
| 2026-03-02 | Puhlmann Markus | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 150,000 | — | $0 | Form 4 |
| 2026-03-02 | Hunt Jonathan Robert | Officer (Chief Accounting Officer) | Grant / award / vesting (derivative) | 90,000 | — | $0 | Form 4 |
| 2026-03-02 | Spoor Johan M. | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 735,000 | — | $0 | Form 4 |
| 2026-03-02 | Woods Lori A | Director | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-03-02 | HENSON HEIDI | Director | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-03-02 | Williamson Robert F III | Director | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-03-02 | Morich Frank | Director | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-03-02 | Martinez Maria E | Director | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2025-11-13 | Hunt Jonathan Robert | Officer (Chief Accounting Officer) | Open-market purchase | 11,000 | $2.03 | $22.3K | Form 4 |
| 2025-11-12 | Williamson Robert F III | Director | Open-market purchase | 9,498 | $2.10 | $19.9K | Form 4 |
| 2025-09-04 | Sendek Joel | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 600,000 | — | $0 | Form 4 |
Ask the chat about CATX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: PERSPECTIVE THERAPEUTICS INC (CATX).
Last updated 2026-09-04 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.